Therapeutic antibodies for human diseases at the dawn of the twenty-first century
Top Cited Papers
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 2 (1) , 52-62
- https://doi.org/10.1038/nrd984
Abstract
Antibodies are highly specific, naturally evolved molecules that recognize and eliminate pathogenic and disease antigens. The past 30 years of antibody research have hinted at the promise of new versatile therapeutic agents to fight cancer, autoimmune diseases and infection. Technology development and the testing of new generations of antibody reagents have altered our view of how they might be used for prophylactic and therapeutic purposes. The therapeutic antibodies of today are genetically engineered molecules that are designed to ensure high specificity and functionality. Some antibodies are loaded with toxic modules, whereas others are designed to function naturally, depending on the therapeutic application. In this review, we discuss various aspects of antibodies that are relevant to their use as as therapeutic agents.Keywords
This publication has 69 references indexed in Scilit:
- Troybodies and PepbodiesBiochemical Society Transactions, 2002
- Stability engineering of antibody single-chain Fv fragmentsJournal of Molecular Biology, 2001
- “Troy-bodies”: Recombinant Antibodies that Target T Cell Epitopes to Antigen Presenting CellsInternational Reviews of Immunology, 2001
- Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokineticsJournal of Molecular Biology, 1999
- Complement recruitment using bispecific diabodiesNature Biotechnology, 1997
- Isolation of High-affinity Monomeric Human Anti-c-erbB-2 Single chain Fv Using Affinity-driven SelectionJournal of Molecular Biology, 1996
- A possible procedure for reducing the immunogenicity of antibody variable domains while preserving their ligand-binding propertiesMolecular Immunology, 1991
- Phage antibodies: filamentous phage displaying antibody variable domainsNature, 1990
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986
- Physicochemical and biological properties of poly(ethylene glycol)-coupled immunoglobuling GBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1984